We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTA
4926
DELISTED
Altabancorp
ALTA
$202K ﹤0.01%
9,048
+6,694
+284% +$138K
TRC icon
4927
Tejon Ranch
TRC
$457M
$201K ﹤0.01%
13,974
+4,904
+54% +$68.3K
USAS
4928
Americas Gold and Silver
USAS
$1.29B
$200K ﹤0.01%
30,292
-414,167
-93% -$2.33M
NPTN
4929
DELISTED
NEOPHOTONICS CORP
NPTN
$200K ﹤0.01%
22,478
+5,149
+30% +$44.4K
GALT icon
4930
Galectin Therapeutics
GALT
$196M
$199K ﹤0.01%
65,192
+9,681
+17% +$24.4K
TXMD icon
4931
TherapeuticsMD
TXMD
$23.5M
$199K ﹤0.01%
3,172
+660
+26% +$38.4K
PCB icon
4932
PCB Bancorp
PCB
$392M
$198K ﹤0.01%
19,172
+11,782
+159% +$107K
TESS
4933
DELISTED
Tessco Technologies Inc
TESS
$198K ﹤0.01%
36,005
+6,079
+20% +$32.3K
FMK
4934
DELISTED
First Trust Mega Cap AlphaDEX Fund
FMK
$198K ﹤0.01%
5,713
-1,770
-24% -$59.4K
LPRO
4935
DELISTED
Open Lending Corp
LPRO
$197K ﹤0.01%
13,053
+12,523
+2,363% +$142K
ALR
4936
DELISTED
AlerisLife Inc
ALR
$197K ﹤0.01%
50,599
-2,438
-5% -$8.69K
ELAT
4937
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
$197K ﹤0.01%
5,236
+1,458
+39% +$58.9K
HEWG
4938
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$196K ﹤0.01%
7,168
-914
-11% -$22.7K
ALX
4939
Alexander's
ALX
$1.3B
$195K ﹤0.01%
809
+448
+124% +$120K
NATH icon
4940
Nathan's Famous
NATH
$402M
$194K ﹤0.01%
3,450
+2,274
+193% +$129K
IDEX
4941
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$194K ﹤0.01%
769
+535
+229% +$61.9K
PAE
4942
DELISTED
PAE Incorporated Class A Common Stock
PAE
$194K ﹤0.01%
20,248
+19,258
+1,945% +$171K
SMC
4943
Summit Midstream
SMC
$426M
$193K ﹤0.01%
12,975
+10,421
+408% +$163K
GNOG
4944
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
$192K ﹤0.01%
11,745
+11,195
+2,035% +$114K
MSON
4945
DELISTED
Misonix Inc
MSON
$192K ﹤0.01%
14,107
+1,977
+16% +$24.2K
FENC icon
4946
Fennec Pharmaceuticals
FENC
$332M
$190K ﹤0.01%
+22,753
New +$169K
PTGX icon
4947
Protagonist Therapeutics
PTGX
$8.79B
$190K ﹤0.01%
10,778
+9,415
+691% +$118K
DXYN
4948
DELISTED
Dixie Group Inc
DXYN
$190K ﹤0.01%
206,575
+77,000
+59% +$58.8K
SOHU
4949
Sohu.com
SOHU
$362M
$189K ﹤0.01%
20,544
+12,683
+161% +$98.9K
AGFS
4950
DELISTED
AgroFresh Solutions Inc
AGFS
$189K ﹤0.01%
62,195
+163
+0.3% +$404

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.